A new report from Paxil’s maker, GlaxoSmithKline, concludes that its popular antidepressant Paxil might make adults with major depression more likely to become suicidal.

According to Sarah Alspach, a spokeswoman for the drug company, “all patients who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.”

The Link between suicide risk and antidepressants has long been a thorny issue for regulators and drugmakers alike.

In 2004, the U.S. Food and Drug Administration (FDA) issued a warning that children and adolescents taking antidepressants might have an increased risk of suicidal thoughts and behaviors.

Specifically, the agency found that 4 percent of children taking antidepressants in clinical trials thought about killing or harming themselves, or actually attempted suicide. By comparison, only 2 percent of children on placebos did so.

In 2006, the FDA extended its warning to include young adults up to age 25. All antidepressant labels must now carry a black box warning stating that they can increase a person’s likelihood of suicidal thoughts and behaviors.

Learn more about Paxil side effects and Paxil lawsuits.

If you or a loved one has been injured by a dangerous or defective drug, contact an RxRecall.com drug recall attorney today. Schedule a free consultation to discuss your legal options.